I
Power Law company profile
iRhythm Technologies
Biotech & Life Sciences · San Francisco, United States · Founded 2006 · IPO 2016 Unicorn
Valuation
$4.12B
Market cap · Apr/2026
Revenue
$747M
Latest reported FY
Global footprint
Where iRhythm Technologies has talent and traffic
AI talent share
0.8%
of workforce is AI talent
(14 of 1,834 staff)
(14 of 1,834 staff)
Core AI80.44%
Other AI60.33%
Non-AI workforce1,82099.24%
Web traffic by country
95K
monthly visits
across markets
across markets
🇺🇸 United States80.2%
🇨🇦 Canada6%
🇮🇳 India3.3%
🇵🇭 Philippines2.9%
🇬🇧 United Kingdom2.5%
Patent intelligence
$70M patent portfolio · 15 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$70M
1.7% of market cap · 13.4× smaller than top peer Globus Medical ($930M)
15 active patent families
Where iRhythm Technologies innovates
Biomedical engineeringRat heartPhysiological monitoringBioinformaticsCardiac arrhythmia
Above peer median on Legal, Market, Technology · Below peer median on Strategic
Quality vs same-sector peers
iRhythm Technologies on the five Patsnap quality dimensions
iRhythm Technologies in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where iRhythm Technologies concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across iRhythm Technologies and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee iRhythm Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.